{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:27:18Z","timestamp":1793366838620,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014367","name":"National Palliative Care Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM07170"],"award-info":[{"award-number":["T32 GM07170"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbcan.2021.188572","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T11:48:00Z","timestamp":1622461680000},"page":"188572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The case for AI-driven cancer clinical trials \u2013 The efficacy arm in silico"],"prefix":"10.1016","volume":"1876","author":[{"given":"Likhitha","family":"Kolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred K.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi B.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbcan.2021.188572_bb0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/17425255.2017.1389897","article-title":"In silico ADME-Tox modeling: progress and prospects","volume":"13","author":"Alqahtani","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"10","key":"10.1016\/j.bbcan.2021.188572_bb0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2021.188572_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5474","article-title":"Evaluation of digital breast tomosynthesis as replacement of full-field digital mammography using an in silico imaging trial","volume":"1","author":"Badano","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188572_bb0020","first-page":"58","article-title":"Patient recruitment driving length and cost of oncology clinical trials","volume":"5","author":"Bianchi","year":"2013","journal-title":"Int. Pharm. Industry"},{"key":"10.1016\/j.bbcan.2021.188572_bb0025","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood-2018-99-117886","article-title":"Preclinical validation studies support causal machine learning based identification of novel drug targets for high-risk multiple myeloma","volume":"132","author":"Bolomsky","year":"2018","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.bbcan.2021.188572_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aay6298","article-title":"Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy","volume":"6","author":"Butner","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2021.188572_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s43441-019-00030-4","article-title":"Improving clinical trial participant prescreening with artificial intelligence (AI): a comparison of the results of AI-assisted vs standard methods in 3 oncology trials","volume":"54","author":"Calaprice-Whitty","year":"2020","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.bbcan.2021.188572_bb0045","series-title":"Statement by FDA Commissioner Scott Gottlieb, M.D., on new strategies to Modernize Clinical Trials to Advance Precision Medicine, Patient Protections and More Efficient Product Development","first-page":"1","author":"FDA","year":"2020"},{"key":"10.1016\/j.bbcan.2021.188572_bb0050","first-page":"3029","article-title":"Multiple myeloma drivers of high risk and response to stem cell transplantation identified by causal machine learning: out-of-cohort and experimental validation","volume":"130","author":"Furchtgott","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2021.188572_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00524","article-title":"Review of causal discovery methods based on graphical models","volume":"10","author":"Glymour","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2021.188572_bb0065","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1182\/blood.V128.22.4406.4406","article-title":"Bayesian network models of multiple myeloma: drivers of high risk and durable response","volume":"128","author":"Gruber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2021.188572_bb0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jech.2004.029496","article-title":"Estimating causal effects from epidemiological data","volume":"60","author":"Hern\u00e1n","year":"2006","journal-title":"J. Epidemiol. Community Health"},{"issue":"5","key":"10.1016\/j.bbcan.2021.188572_bb0080","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/cncr.27854","article-title":"Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials","volume":"119","author":"Hui","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2021.188572_bb0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/amiajnl-2011-000163","article-title":"A study of machine-learning-based approaches to extract clinical entities and their assertions from discharge summaries","volume":"18","author":"Jiang","year":"2011","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.bbcan.2021.188572_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/leu.2017.197","article-title":"Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma","volume":"32","author":"Lagan\u00e0","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188572_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.9.2.13","article-title":"Applications of artificial intelligence to electronic health record data in ophthalmology","volume":"9","author":"Lin","year":"2020","journal-title":"Trans. Vision Sci. Technol."},{"key":"10.1016\/j.bbcan.2021.188572_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01198","article-title":"Deep feature selection and causal analysis of Alzheimer's disease","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbcan.2021.188572_bb0110","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/cancers11101452","article-title":"A network analysis of multiple myeloma related gene signatures","volume":"11","author":"Liu","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2021.188572_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.7","article-title":"The role of modeling and simulation in development and registration of medicinal products: output from the efpia\/ema modeling and simulation workshop","volume":"2","author":"Manolis","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.bbcan.2021.188572_bb0120","article-title":"Predicting dementia with routine care EMR","author":"Miled","year":"2020","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.bbcan.2021.188572_bb0130","series-title":"Food and Drug Administration","article-title":"How simulation can transform regulatory pathways","author":"Morrison","year":"2018"},{"issue":"1","key":"10.1016\/j.bbcan.2021.188572_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-019-1724-1","article-title":"Genomics and data science: an application within an umbrella","volume":"20","author":"Navarro","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2021.188572_bb0140","author":"Nelson"},{"key":"10.1016\/j.bbcan.2021.188572_bb0145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1200\/CCI.20.00059","article-title":"Improving cancer data interoperability: the promise of the minimal common oncology data elements (mCODE) initiative","volume":"4","author":"Osterman","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188572_bb0150","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2016.0163","article-title":"A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator","volume":"8","author":"Ouzounoglou","year":"2018","journal-title":"Interface Focus"},{"key":"10.1016\/j.bbcan.2021.188572_bb0155","series-title":"Intelligent Clinical Trials","first-page":"34","author":"Properzi","year":"2020"},{"issue":"1","key":"10.1016\/j.bbcan.2021.188572_bb0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jvs.2019.12.026","article-title":"Artificial intelligence in abdominal aortice aneurysm","volume":"72","author":"Raffort","year":"2020","journal-title":"J. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.bbcan.2021.188572_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-221","article-title":"Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis","volume":"14","author":"Schmidt","year":"2013","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.bbcan.2021.188572_bb0170","series-title":"The Case for Causal AI. Stanford Social Innovation Review, Summer","first-page":"50","author":"Sgaier","year":"2020"},{"issue":"15_suppl","key":"10.1016\/j.bbcan.2021.188572_bb0175","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e19528","article-title":"Superior therapy response predictions for patients with myelodysplastic syndrome (MDS) using Cellworks Singula: MyCare-009-02","volume":"38","author":"Stein","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"June","key":"10.1016\/j.bbcan.2021.188572_bb0180","first-page":"22","article-title":"Clinical development success rates","volume":"June","author":"Thomas","year":"2016","journal-title":"BioMedTracker"},{"key":"10.1016\/j.bbcan.2021.188572_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/CLEP.S242097","article-title":"Synthetic and external controls in clinical trials \u2013 A primer for researchers","volume":"12","author":"Thorlund","year":"2020","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.bbcan.2021.188572_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/djy221","article-title":"Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation","volume":"111","author":"Unger","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.bbcan.2021.188572_bb0195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/1759-7714.12641","article-title":"Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancer","volume":"9","author":"Yoo","year":"2018","journal-title":"Thorac. Cancer."},{"key":"10.1016\/j.bbcan.2021.188572_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/2326-6074.TUMIMM18-A17","article-title":"Abstract A17: predictions of comparative clinical outcomes for checkpoint inhibitor combo therapies and mechanistic targets in first-line NSCLC","volume":"8","author":"Vanderman","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2021.188572_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.18203\/2349-3259.ijct20161408","article-title":"In silico clinical trials: how computer simulation will transform the biomedical industry","volume":"3","author":"Viceconti","year":"2016","journal-title":"Int. J. Clin. Trials"},{"issue":"7","key":"10.1016\/j.bbcan.2021.188572_bb0210","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gr.157602.113","article-title":"From human genome to cancer genome: the first decade","volume":"23","author":"Wheeler","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.bbcan.2021.188572_bb0690","doi-asserted-by":"crossref","unstructured":"J. Pearl, Causality: Models, Reasoning and Inference (2nd. ed.). Cambridge University Press, USA. (2009).","DOI":"10.1017\/CBO9780511803161"},{"key":"10.1016\/j.bbcan.2021.188572_bb0070","series-title":"To Build Truly Intelligent Machines, Teach Them Cause and Effect","author":"K","year":"2018"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2100069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2100069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:48:09Z","timestamp":1759639689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2100069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0304419X2100069X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188572","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case for AI-driven cancer clinical trials \u2013 The efficacy arm in silico","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188572"}}